Synaptogenix Inc (SNPX)

[runncoach]

Whatsupp, after looking at the 10k here is what the agreement with stanford states. I would think MS would fall under that language but I don't know for sure. Might be one of the opportunities they could sub license to someone else? Regardless, anyone who investigates along those lines would have a keen interest in other indications for bryostatin and our research on those. JMHO

"Importantly, we have now obtained an exclusive license for neurologic disorders to a new, accelerated synthesis of bryostatin-1 recently developed at Stanford University by Dr. Paul Wender and his team."

"On May 12, 2014, we entered into a license agreement (the “Stanford License”) with The Board of Trustees of the Leland Stanford Junior University (“Stanford”) pursuant to which Stanford has granted to us a revenue-bearing, world-wide right and exclusive license, with the right to grant sublicenses (on certain conditions), under three issued U.S. patents and one pending U.S. patent and related technology for the use of bryostatin structural derivatives, known as “bryologs,” for use in the treatment of central nervous system disorders, lysosomal storage diseases, stroke, cardioprotection and traumatic brain injury, collectively referred to as the Licensed Field of Use, for the life of the licensed patents. As mentioned above, in January 2017, we entered into an additional license agreement with Stanford relating to an accelerated synthesis of bryostatin-1."